- Home
- OBIO vs DSX Comparison
OBIO vs DSX Comparison
Compare OBIO & DSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- DSX
- Stock Information
- Founded
- OBIO 2017
- DSX 1999
- Country
- OBIO United States
- DSX Greece
- Employees
- OBIO N/A
- DSX N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- DSX Marine Transportation
- Sector
- OBIO Health Care
- DSX Consumer Discretionary
- Exchange
- OBIO Nasdaq
- DSX Nasdaq
- Market Cap
- OBIO 151.3M
- DSX 172.5M
- IPO Year
- OBIO N/A
- DSX 2005
- Fundamental
- Price
- OBIO $2.85
- DSX $1.52
- Analyst Decision
- OBIO Strong Buy
- DSX
- Analyst Count
- OBIO 5
- DSX 0
- Target Price
- OBIO $14.20
- DSX N/A
- AVG Volume (30 Days)
- OBIO 193.1K
- DSX 257.9K
- Earning Date
- OBIO 05-12-2025
- DSX 05-29-2025
- Dividend Yield
- OBIO N/A
- DSX 2.63%
- EPS Growth
- OBIO N/A
- DSX N/A
- EPS
- OBIO N/A
- DSX 0.05
- Revenue
- OBIO $2,886,000.00
- DSX $225,498,000.00
- Revenue This Year
- OBIO $21.38
- DSX N/A
- Revenue Next Year
- OBIO $31.89
- DSX $12.03
- P/E Ratio
- OBIO N/A
- DSX $28.79
- Revenue Growth
- OBIO 30.23
- DSX N/A
- 52 Week Low
- OBIO $2.37
- DSX $1.27
- 52 Week High
- OBIO $8.87
- DSX $3.07
- Technical
- Relative Strength Index (RSI)
- OBIO 49.08
- DSX 53.14
- Support Level
- OBIO $2.61
- DSX $1.38
- Resistance Level
- OBIO $3.02
- DSX $1.59
- Average True Range (ATR)
- OBIO 0.18
- DSX 0.07
- MACD
- OBIO 0.04
- DSX 0.00
- Stochastic Oscillator
- OBIO 60.19
- DSX 66.67
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About DSX Diana Shipping inc. common stock
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.